CareLit Fachartikel

Proteasome inhibition during oncolytic infection improves antitumoral immunity and inhibits metastatic growth of HCC

B Boozari, B Mundt, N Woller, E Gürlevik, P Schache, M Manns, S Kubicka, F Kühnel · Zeitschrift für Gastroenterologie · 2010 · Heft 01

Dokument
1138272
CareLit-ID
Jahr
2010
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
B Boozari, B Mundt, N Woller, E Gürlevik, P Schache, M Manns, S Kubicka, F Kühnel
Ausgabe
Heft 01 / 2010
Seiten
–
Erschienen: 2010-01-12 00:00:00
ISSN
0044-2771

Zusammenfassung

Infection of a dying cell by a pathogen dictates the immune response against intracellular antigens, but the impact of tumor cell death during oncolytic viral infection on the induction of antitumoral immunity is unknown. Recently, ER-stress due to disruption of the unfolded-protein-response (UPR) has been implicated in the bypass of immune tolerance mechanisms. Since viruses and proteasome inhibitors both induce accumulation of misfolded proteins, we investigated ER-stress mediated apoptosis and antitumoral immune responses in mouse models of hepatocellular carcinoma after treatment with the proteasome inhibito…

Schlagworte

ER stress HCC immunotherapy oncolytic proteasome virotherapy Apoptosis Bortezomib Tumor Antigens After Zeitschrift für Gastroenterologie